|1.||Pan, Li: 2 articles (11/2013 - 03/2009)|
|2.||Kinghorn, A Douglas: 2 articles (11/2013 - 03/2009)|
|3.||Bueno Pérez, Lynette: 1 article (11/2013)|
|4.||Sass, Ellen: 1 article (11/2013)|
|5.||Lucas, David M: 1 article (11/2013)|
|6.||Gupta, Sneha V: 1 article (11/2013)|
|7.||Lehman, Amy: 1 article (11/2013)|
|8.||Kang, Sam Sik: 1 article (10/2013)|
|9.||Park, Hyen Joo: 1 article (10/2013)|
|10.||Kim, Won Kyung: 1 article (10/2013)|
|1.||Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/01/2013 - "The potentiating action of the flavonolignan, (-)-hydnocarpin, in combination with vincristine was evaluated in the 697 acute lymphoblastic leukemia cell line and a P-gp-expressing variant, 697-R. "
11/01/2013 - "Potentiating effect of the flavonolignan (-)-hydnocarpin in combination with vincristine in a sensitive and P-gp-expressing acute lymphoblastic leukemia cell line."
|4.||Colonic Neoplasms (Colon Cancer)
10/15/2013 - "The anti-proliferative activity of hydnocarpin was also found to be associated with the suppression of Wnt/β-catenin-mediated signaling pathway in human colon cancer cells. "
10/15/2013 - "Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells."
|5.||Breast Neoplasms (Breast Cancer)